Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21
about
The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factorsThe role of microRNA genes in papillary thyroid carcinomaEvidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosusFamilial multinodular goiter syndrome with papillary thyroid carcinomas: mutational analysis of the associated genes in 5 cases from 1 Chinese familyBeyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer.Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies.Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia.Molecular approaches to thyroid cancer diagnosis.Old and new insights in the treatment of thyroid carcinoma.Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetranceCommon SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinomaControversies in familial thyroid cancer 2014Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predispositionFamilial follicular cell-derived thyroid carcinoma.Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid CancerA genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer.Familial nonmedullary thyroid carcinoma.The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.New developments in the diagnosis and treatment of thyroid cancer.Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.Neuroendocrine tumors and tumor syndromes in childhood.Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?The familial counterparts of follicular cell--derived thyroid tumors.The pathologist's role in familial nonmedullary thyroid tumors.Telomeres and thyroid cancerTelomerase and the endocrine system.Personalized medicine: caught between hope, hype and the real worldGenetic predisposition for nonmedullary thyroid cancer.Hereditary thyroid cancer syndromes and genetic testing.The impact of family history on non-medullary thyroid cancer.Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells.Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.TOM: a web-based integrated approach for identification of candidate disease genes.Unraveling the genetic predisposition to differentiated thyroid carcinoma.Frequency of thyroid carcinoma and thyroid autoimmunity in first-degree relatives of patients with papillary thyroid carcinoma: a single center experience.
P2860
Q21092455-58E11671-D26D-4051-A81D-A154FB9585F2Q24535848-BD0000E2-7ECC-4D91-8D96-0AA4C7DC838BQ24535928-694159F9-6DE5-44C9-A8DD-093170F60568Q33589733-2F120571-E169-43A5-A785-94BD494C8506Q33679037-08C3C37D-628E-404B-9C50-A00F9642BBBEQ33760096-E871EDE8-CFB7-4008-ADEC-7421C5D7667EQ33984801-5EE7661E-FC00-42CC-B1C8-A4EF86A37601Q34154306-A1ED01E4-F108-4324-B53B-A5A8DF9D8998Q34160828-1D7287D9-D0A0-4B75-88DC-CBA4955383BEQ34209934-5CB82E3C-1BD1-4617-AFD6-E2B4AC75C157Q34729785-218D165F-FA00-46F9-9A28-4DD274157DA7Q34778280-9AC2EBA1-DD67-4B76-AAEF-57A9B9F71BBCQ35233466-273DD104-3E8F-4DF6-B231-D99E4CF24F52Q35439328-59CEE81E-763C-41C8-9573-FBDEBAB744C2Q35445970-B55FB134-6472-43B2-AE89-BDBDA914BC2BQ35809227-D3D53F7C-C185-4947-8C75-18C345A7E1BBQ35971943-09C2F9AB-AE52-4DC4-B323-72403C950906Q36245933-3FB959C9-3700-4F72-9A53-3C8D459056C9Q36416317-4703084C-7059-44AA-822F-7CC4AD3E6C8BQ36493217-B5DFD504-D849-4021-8238-15F2BF3EE79BQ36716116-81AE171A-D421-4F38-955D-B755B81D7515Q36817184-A9A0E720-B1B7-44C8-85D5-2BC62AA3365BQ37080732-01A03139-28D6-4DF1-AE15-37A4BCA1635AQ37238757-E6DD51E5-DB2E-4BC7-9BAA-61003AF47E8BQ37403877-7A57C140-8508-4EF7-97DE-3D8C3999145FQ37587164-3A7DA24E-F9C8-4A71-ABF0-8301F5F0653DQ37691819-6E9B5117-BB09-4CA8-938A-7B057BA7523EQ37742941-DD81E40F-8C63-4253-955F-E820688DBFA6Q37756404-8B26CDC7-B585-4682-9AC9-72606AB70637Q37761836-E76A5379-91C9-4B45-8F71-A67F75642FCCQ37859251-524A4E30-96A7-45EF-9230-97E06D2EF449Q38010031-49FC6A2D-83E4-4338-9AD7-FE67156F7145Q38261984-3C778F0D-E680-4946-A8F5-5A108C78A0EBQ38263389-89EBA2F9-9A0D-4091-82D3-B93BFDE00E47Q38937305-FD956ABD-4A8B-46D6-83C4-A0E2AC891771Q39634789-F3355977-717C-44B5-9A9B-2427C65636C0Q40718437-D1D21EDC-A690-46DC-B8CD-AEE2FA02E27CQ42246804-8F7B52D9-AAF4-4A15-A2DB-1EAF42E5DA79Q42957205-82261CA7-8019-4A0C-955F-4D3442A66A34Q43662955-16D8E9C3-A1A1-4D5B-817F-7708DD68979E
P2860
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@ast
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@en
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@nl
type
label
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@ast
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@en
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@nl
prefLabel
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@ast
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@en
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@nl
P2093
P2860
P356
P1476
Localization of a susceptibili ...... d carcinoma to chromosome 2q21
@en
P2093
A Duffield
A M Bernard
D E Goldgar
F Bonichon
P2860
P304
P356
10.1086/321979
P407
P577
2001-07-02T00:00:00Z